GRI (STOCKS)
GRI Bio, Inc. Common Stock
$2.301300
-0.148700 (-6.07%)
Prev close: $2.450000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- W. Marc Hertz
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3.45M
- Employees
- 4
- P/E (TTM)
- -0.01
- P/B (TTM)
- 0.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-116.61 | $-29.55 | -87.0574 | -294.58% |
|
Sep 2025 (Q3)
|
$-35.84 | $-26.30 | -9.5396 | -36.27% |
|
Jun 2025 (Q2)
|
$-36.68 | $-37.05 | +0.3668 | +0.99% |
|
Mar 2025 (Q1)
|
$-162.40 | $-116.23 | -46.1692 | -39.72% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $11.98M |
| Research and Development | $6.82M |
| Other Operating Expenses | $5.16M |
| Operating Income/Loss | -$11.98M |
| Income/Loss From Continuing Operations After Tax | -$11.96M |
| Income/Loss From Continuing Operations Before Tax | -$11.95M |
| Income Tax Expense/Benefit | $3.00K |
| Net Income/Loss | -$11.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$121.80 |
| Diluted Earnings Per Share | -$121.80 |
| Basic Average Shares | 98,162 |
| Diluted Average Shares | 98,162 |
| Assets | $8.67M |
| Current Assets | $8.59M |
| Noncurrent Assets | $74.00K |
| Fixed Assets | $3.00K |
| Other Non-current Assets | $71.00K |
| Liabilities | $2.66M |
| Current Liabilities | $2.64M |
| Accounts Payable | $1.84M |
| Wages | $336.00K |
| Other Current Liabilities | $470.00K |
| Noncurrent Liabilities | $15.00K |
| Equity | $6.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.01M |
| Liabilities And Equity | $8.67M |
| Net Cash Flow From Operating Activities | -$10.19M |
| Net Cash Flow From Operating Activities, Continuing | -$10.19M |
| Net Cash Flow From Investing Activities | -$3.00K |
| Net Cash Flow From Investing Activities, Continuing | -$3.00K |
| Net Cash Flow From Financing Activities | $13.39M |
| Net Cash Flow From Financing Activities, Continuing | $13.39M |
| Net Cash Flow | $3.20M |
| Net Cash Flow, Continuing | $3.20M |
| Comprehensive Income/Loss | -$11.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.96M |
| Other Comprehensive Income/Loss | $0.00 |